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Dowling-Degos disease (DDD) is an autosomal dominant genodermatosis characterized by progressive and disfig-
uring reticulate hyperpigmentation of the flexures. We performed a genomewide linkage analysis of two German
families and mapped DDD to chromosome 12q, with a total LOD score of 4.42 ( ) for marker D12S368.vp 0.0
This region includes the keratin gene cluster, which we screened for mutations. We identified loss-of-function
mutations in the keratin 5 gene (KRT5) in all affected family members and in six unrelated patients with DDD.
These represent the first identified mutations that lead to haploinsufficiency in a keratin gene. The identification
of loss-of-function mutations, along with the results from additional functional studies, suggest a crucial role for
keratins in the organization of cell adhesion, melanosome uptake, organelle transport, and nuclear anchorage.
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Dowling-Degos disease (DDD [MIM 179850]) is an au-
tosomal dominant form of a reticulate pigmentary dis-
order. This rare genodermatosis was first described by
Dowling and Freudenthal in 1938 and was termed der-
matose reticule´e des plis by Degos and Ossipowski
[1954]. Further families and individual cases have since
been reported (Crovato et al. 1983; Biltz and Kiessling
1988; Milde et al. 1994).
Affected individuals develop a postpubertal reticulate
hyperpigmentation that is progressive and disfiguring
and small hyperkeratotic dark-brown papules that
mainly affect the flexures and great skin folds (fig. 1A
and 1B). Pitted perioral acneiform scars (Jones and Grice
1978; Crovato et al. 1983) and genital and perianal re-
ticulated pigmented lesions have also been described
(Milde et al. 1992; O’Goshi et al. 2001; Jafari et al.
2003). Patients usually show no abnormalities of the
hair or nails, though burning or itching does occur in
some patients. Histology shows filiform epithelial down-
growth of epidermal rete ridges, with a concentration of
melanin at the tips. No effective therapy is yet available.
Differential diagnosis is sometimes complicated by the
clinical overlap with other reticulate pigmentary disor-
ders. The disorder that most closely resembles DDD is
reticulate acropigmentation of Kitamura, for which lo-
cation of the pigmented lesions is primarily acral, onset
is within the first 2 decades of life, and palmar and
plantar pits are commonly found (Griffiths 1984).
No studies of the molecular genetic basis of DDD are,
to our knowledge, available to date. Here, we describe
localization of the first DDD locus on chromosome 12q
and provide evidence that loss-of-function mutations in
the keratin 5 gene (KRT5) lead to DDD and are sug-
gestive of a crucial role for keratins in the organization
of cell adhesion, melanosome uptake, organelle trans-
port, and nuclear anchorage.
Methods and Results
To identify the causative gene defect, we collected blood
samples from two German pedigrees described elsewhere
(Biltz and Kiessling 1988; Milde et al. 1994) and com-
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posed of 24 individuals, 9 of whom were affected. In-
formed consent was obtained from all participants.
DNA was prepared in accordance with standard meth-
ods. The detailed clinical data of these families have been
presented elsewhere (Biltz and Kiessling 1988; Milde et
al. 1994).
As a first step, a total genome scan was performed
using 500 highly polymorphic microsatellite markers, at
an average 8-cM density. Two-point LOD scores were
calculated between each marker locus and DDD, with
the use of LINKAGE version 5.1 software (Lathrop et
al. 1984) and with the assumption of autosomal dom-
inant inheritance, equal male and female recombination
rates, a model of 95% penetrance (phenocopy rate 1%),
and a disease-allele frequency of 0.0001. We found evi-
dence of linkage to the marker D12S368, with a max-
imum cumulative LOD score of 4.42 ( ). Hap-vp 0.0
lotypes were then reconstructed to determine the critical
recombination events. A common haplotype spanning a
20.6-Mb region on chromosome 12q13.11-12q15
flanked by microsatellite markers D12S85 and
D12S1294 (fig. 1C) segregated in all affected family
members. A search for candidate genes in this region
identified the keratin (KRT) gene cluster that contains
strong candidate genes for a skin disease. We amplified
by PCR and directly sequenced the region encoding the
rod domains of the possible candidate genes KRT1,
KRT5, KRT6A, KRT6B, and KRT6L, including the
exon-intron boundaries in two patients and in one un-
affected individual from our DDD-affected families. The
PCR products were purified with the GFX PCR DNA
Purification Kit (Amersham Biosciences) and were di-
rectly sequenced using the BigDye Terminator v1.1 Cycle
Sequencing Kit (Applied Biosystems) on an ABI 3100
genetic analyzer (Applied Biosystems). In two patients,
we found a single adenine base insertion in the KRT5
gene (c.418dupA; p.Ile140AsnfsX39 [GenBank acces-
sion numbers NM_000424 and NP_000415]) (figs. 1D
and 1E), that led to a frameshift and that resulted in a
premature termination of translation at codon 178. We
observed full segregation of p.Ile140fs in the respective
families. Haplotype and SNP analysis revealed that the
mutation arose on the same genetic background in the
two families, suggesting a common ancestor. In addition,
we screened eight patients not belonging to the original
pedigrees for all exons of KRT5. For three of them, no
family history was known (Wenzel et al. 2002; Braun-
Falco and Ring 2003). The disorder in three patients
seemed to be sporadic, since parents and siblings of these
patients were reported as being unaffected (Ru¨tten and
Strauß 1995; Wenzel et al. 2002); one patient had an
affected father, and the last patient had an affected
mother and sister (Braun-Falco et al. 2001). In five of
the eight screened patients, the p.Ile140fs mutation was
also identified; among them were the two familial cases
(Braun-Falco et al. 2001), one patient with an unknown
family history, and two patients who were reported as
sporadic cases (Ru¨tten and Strauß 1995; Wenzel et al.
2002). Genotyping of additional markers around the
mutation showed a result compatible with the existence
of a common ancestor for all affected individuals. How-
ever, a large number of SNPs were uninformative, and
haplotypes could not be constructed for those patients
for whom DNA from additional family members was
not available. We also found a nonsense mutation re-
sulting in a premature stop codon (c.14CrA; p.Ser5X)
(fig. 1D and 1E) in one patient with DDD (Braun-Falco
and Ring 2003). No information on family history was
available for this patient. We found no mutation in
KRT5 in two of the eight patients.
Neither the mutation p.Ile140fs nor p.Ser5X was de-
tected among 530 control chromosomes of German or-
igin. Previous studies have demonstrated a role for ker-
atin 5 (K5) in the pathogenesis of epidermolysis bullosa
simplex (EBS) (Magin et al. 2004; Omary et al. 2004).
None of the individuals with DDD whom we investi-
gated, however, showed additional skin abnormalities.
K5 and K14 form the intermediate filament (IF) cy-
toskeleton in basal keratinocytes of stratified epithelia
and belong to the type I and type II gene families of IF
proteins, which encompass 28 and 26 members in the
two families, respectively (Hesse et al. 2001, 2004). In
epithelia, distinct pairs of a type I and a type II protein
are expressed to form an IF cytoskeleton with unique
mechanical properties. They show specific interactions
with desmosomal and hemidesmosomal plakins and ar-
madillo proteins (Fontao et al. 2003; Getsios et al. 2004;
Magin et al. 2004). The primary control of keratin ex-
pression occurs at the transcriptional level individually
for each gene and serves to produce equal amounts of
type I and type II keratin mRNAs (Coulombe and Wong
2004). All keratins consist of an extended a-helical rod
domain flanked by a carboxyterminal tail and an ami-
noterminal head domain, the latter of which is crucial
for IF formation. Assembly proceeds through formation
of heterodimeric coiled coils of a type I and a type II
keratin into higher-order structures. Their formation re-
quires the head domain (Herrmann and Aebi 2004). Un-
paired type I and II proteins are normally degraded but
can be stabilized by being bound to associated proteins,
including small chaperones and 14-3-3 proteins (Cou-
lombe and Wong 2004). Discovery of disease mutations
has revealed that the interaction of keratins with des-
mosomes and the nuclear envelope is crucial for the for-
mation of a supracellular cytoskeleton, signal transduc-
tion, and the protection of the epidermis against stress
(Omary et al. 2004). To date, all mutations identified in
K5 have been missense mutations acting as dominant-
negative mutations. Mutations at the rod-end domains
lead to aggregation of the cytoskeleton and cause severe
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Figure 1 Clinical appearance and underlying genetic defect of DDD. A and B, Reticulate hyperpigmentation and hyperkeratotic dark-
brown papules on the neck and the axilla of individual II:13 (pedigree DDD 1). C, Two pedigrees segregating for DDD. Marker haplotypes
on chromosome 12q13.11-12q15 that are linked to DDD are indicated by black bars. D, Sequence analysis showing the c.418dupA and c.14CrA
mutations in patients with DDD. E, Domain structure and position of mutations in K5. Head and tail domains are marked in blue. Conserved
helical end domains are marked in green, and nonhelical linker domains L1, L12, and L2 are marked with yellow bars. 1A, 1B, 2A, and 2B
indicate rod subdomains. The thin red line in coil 2B indicates the “stutter.” H1 and H2 are conserved a-helical subdomains flanking the rod.
The head domain extends from aa 1 to 132, H1 from 133 to 158, 1A from 159 to 203, 1B from 216 to 316, 2A from 334 to 352, 2B from
360 to 481, H2 from 481 to 501, and the tail domain from 502 to 590. The positions of the mutations p.Ser5X (c.14CrA) and p.Ile140AsnfsX39
(c.418dupA) are indicated by black arrowheads. Mutations causing EBS are marked by black lines. Detailed information about the localization
of EBS mutations is available at the Human Intermediate Filament Mutation Database. The residual K5 polypeptides are generated by the
p.Ser5X and p.Ile140AsnfsX39 mutations. The truncated K5 protein caused by p.Ile140AsnfsX39 encompasses positions 1–139 of K5 and 39
aa of an incorrect reading frame (gray bar).
forms of EBS. Mutations in other regions of the rod
domains cause milder forms of EBS, whereas those in
the K5 tail domain cause migratory circinate erythema,
possibly by affecting the interaction between desmo-
somes and keratins (Gu et al. 2003; Magin et al. 2004).
We performed further studies to understand the func-
tional consequences and to exclude a dominant-negative
effect of p.Ile140fs, which leaves most of the head do-
main intact. By amplifying the predicted mutant K5
mRNA by RT-PCR, we found a similar abundance of
normal and mutant cDNAs, a finding that is in agree-
ment with the prediction based on the position of the
mutation (Maquat 2005). Skin biopsies from patients
with p.Ile140fs and from control individuals were ex-
amined by light and electron microscopy. Histology and
electron microscopy were performed as described by Rei-
chelt et al. (2001). Fontana-Masson staining of paraffin-
embedded sections was performed as described by Byers
et al. (2003). Affected individuals displayed papillary
downgrowth of the epidermis accompanied by filiform
extensions of basal keratinocytes into the dermis (figs.
2A and 3A; for a control, see figs. 2B and 3B). Their
melanosomes had a scattered distribution throughout
basal keratinocytes and appeared irregularly shaped,
whereas, in controls, they maintained their supranuclear
caplike pattern (fig. 2C and 2D). In addition, melan-
osomes persisted throughout the epidermis of affected
individuals, suggesting a delayed degradation (fig. 2C;
for a control, see fig. 2D). Examination of semithin sec-
tions of affected skin revealed a locally altered epidermal
morphology with keratinocytes of irregular shape and
size. The basal aspect of mutant keratinocytes displayed
long and irregular extensions into the dermis (fig. 3A),
in contrast to controls (fig. 3B). Most notably, the nuclei
of suprabasal but not of basal cells displayed an IF-free
halo of cytoplasm with few residual organelles, sug-
gesting an altered organization of perinuclear keratin IF
(fig. 3C and 3D). The haphazard distribution of melan-
osomes was confirmed by ultrastructural analysis (fig.
3C). At higher resolution, it became apparent that the
organization of melanin pigments in melanosomes was
irregular, indicating that they represented stage III and
IV organelles (fig. 3E). The overall length of keratin
filaments, however, was very similar to that in control
samples. Filaments displayed no tendency to aggregate
or to bundle and maintained their connection to hemi-
desmosomes and desmosomes (fig. 3F and 3G). There
was no cytolysis. The observed alterations were very
similar, if not identical, to those reported elsewhere for
the patient bearing the p.Ser5X mutation (Braun-Falco
and Ring 2003).
We examined keratin expression with antibodies
against the K5 carboxyterminus, K14, K1, and K10.
Furthermore, we produced a novel K5 head domain-
specific antiserum (fig. 4A–D). This revealed no major
difference between DDD and control cells. Stable trans-
fection of MCF-7 and HaCaT cells with an EYFP-
p.Ile140fs construct followed by immunofluorescence
analysis showed a diffuse distribution of the mutant pro-
tein (fig. 5A). The K5 expression construct EYFP-
p.Ile140fs was created as follows. A K5 cDNA was syn-
thesized from human HaCaT keratinocytes, with amp-
limers 5′-AAGCTCTCGCCAGTCAAGTGTGTCC-3′
and 5′-CATTTTATTGAACACATTCTGGAGG-3′.
These replaced the translation start codon with a HindIII
restriction site. The cDNA was cloned into the pCR II-
TOPO vector (Invitrogen). Using the QuikChange Site-
Directed Mutagenesis Kit (Stratagene), we created the
mutation with the forward and reverse primers 5′-GCC-
CTCCTGGAGGTAATCCAAGAGGTCACTG-3′ and
5′-CAGTGACCTCTTGGATTACCTCCAGGAGGGC-
3′, respectively, and verified it by sequence analysis. The
mutated K5 was then cloned into the HindIII/XbaI site
of the pEYFP-C1 vector (BD Biosciences Clontech). The
mutation leads to a frameshift in K5 at position Ile140,
resulting in the following aberrant protein sequence
starting at position 140: NPRGHCQPESPDSPQPANR-
PQHPEGEDRGARADQDPQQ.
MCF-7 cells were cultivated and transfected as de-
scribed elsewhere (Werner et al. 2004). Human HaCaT
keratinocytes were cultured in Dulbecco’s modified Ea-
gle medium supplemented with 10% fetal calf serum and
transfected with calcium phosphate mammalian cell
transfection kit (Eppendorf 5 Prime). Stably transfected
514 The American Journal of Human Genetics Volume 78 March 2006 www.ajhg.org
Figure 2 Light microscopy and Fontana-Masson staining of sections from DDD and control skin. A, Hematoxylin and eosin staining of
sections from DDD demonstrates papillary epidermal downgrowth, in contrast to control skin (B). C, Fontana-Masson staining shows scattered
distribution of melanosomes in patients with DDD. D, Regular, nuclear caplike structure of melanosomes in control skin. Scale bar represents
50 mm.
cells were selected in the presence of 700 mg/ml geneticin
(Invitrogen). Immunofluorescence analysis was per-
formed as described elsewhere (Reichelt and Magin
2002). The following antibodies were used: B5-1-2
against a-tubulin (1:1,000) (Sigma), MAB1618 against
dynein intermediate chain (1:50) (Chemicon), Ks18.4
against K18 (1:10) (Progen), K14 LL001 against K14
(neat) (gift from B. Lane) and K5-head against the K5-
head domain (1:2,000) (Magin), Ks8.60 against K1/
K10/K11 (1:200) (Sigma), ab6276 against beta actin
(1:400) (abcam), 5C2 against plakophillin 1 (neat), a-
plakophilin 2 (neat) (gift from W. Franke), and a-plak-
ophilin 3 (1:300) (Zymed), and Il-5F against desmo-
plakin (1:50) (gift from D. Garrod). Secondary anti-
bodies were Alexa 488 or 594 conjugated goat a-mouse
(1:400) and a-guinea pig (1:400) antisera (Molecular
Probes). Double-immunofluorescence with antibodies to
desmoplakin, plakophilins 1–3, and a-tubulin (fig. 5D–
F and 5H–J) revealed no colocalization or mistargeting
of these proteins under the fixation conditions used. In
accordance with electron microscopy data, this excluded
a role of the K5 head in desmoplakin anchorage, con-
trary to biochemical data reported elsewhere (Smith and
Fuchs 1998). Using an antibody against dynein inter-
mediate chain, we noted a partial colocalization of the
EYFP-K5 mutant at the nuclear periphery (fig. 5G).
Fractionation of cell extracts was performed as de-
scribed elsewhere (Werner et al. 2004). Total protein
extracts were prepared as published elsewhere (Reichelt
et al. 1999) and were subjected to SDS-PAGE. The fol-
lowing antibodies were used: Jl-8 against YFP (1:
10,000) (BD Biosciences Clontech), Ks18.4 against K18,
Ks8.7 against K8, and Ks19.2 against K19 (each 1:
15,000) (Progen). Secondary antibodies were horserad-
ish peroxidase-coupled goat a-mouse (1:30,000) anti-
sera (Dianova). Fractionation of MCF-7 cells transfected
with an EYFP-fusion protein construct into soluble and
cytoskeletal proteins, followed by Western blotting,
demonstrated that the p.Ile140fs polypeptide was not
incorporated into the intermediate filament network but
remained completely in the soluble fraction (fig. 5K). In
most in vivo settings, the soluble fraction of keratins is
Figure 3 Electron microscopy of skin from an individual with DDD and from a control. A, Semithin sections from a patient with DDD
with filiform epithelial downgrowth (arrows), in contrast to control skin (B). Note irregular DDD cell shape and size in (A). C–G, Ultrathin
sections from a patient with DDD with scattered distribution of melanosomes (E) and altered perinuclear organization of keratins in suprabasal
but not in basal cells. C and D, Perinuclear rim of filament-free, smooth cytoplasm is demarcated by arrowheads; SC p spinous cell. K5
haploinsufficiency allows formation of normal keratin filaments and their interaction with hemidesmosomes (F) and desmosomes (G). Scale
bars represent 20 mm (A and B), 25 mm (C), 500 nm (D and E), and 200 nm (F and G).
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Figure 4 Immunofluorescence analysis of skin sections. Skin sections from a patient with DDD (A and C) and from an unaffected individual
(B and D) stained with antibodies against K5 and K14 (A and B) and K10 (C and D) revealed no differences in the distribution and organization
of keratins. Note the presence of terminally differentiated cells in the papillary downgrowth. The dashed lines in panels C and D indicate the
basal lamina. Scale bar represents 50 mm.
very small, but phosphorylation of Ser residues in the
head domains can lead to an increase in soluble keratins
and is a prerequisite for the dynamic rearrangement of
the cytoskeleton during cell differentiation, migration,
and mitosis (Herrmann and Aebi 2004; Omary et al.
2004).
Discussion
The notion that the previously described KRT5 mutation
p.Pro25Leu causes EBS with mottled pigmentation (Ut-
tam et al. 1996) is suggestive of a distinct role for K5
in melanosome transport. With the exception of K14,
for which a few nonsense mutations causing recessive
and mild forms of EBS have been reported (e.g., Rugg
et al. 1994), no nonsense mutations have been described
in any other keratin genes to date. We have demon-
strated for the first time that haploinsufficiency in a ker-
atin gene causes epithelial remodeling, melanosome mis-
targeting, and altered perinuclear organization of IF—
phenotypes otherwise described for molecules such as
b-catenin, Rab27a, and nesprins (Marks and Seabra
2001; Jamora et al. 2003; Gruenbaum et al. 2005). The
finding that the desmosomal cadherin desmocollin-3 is
relocalized in one of our patients with DDD (Braun-
Falco and Ring 2003) strongly suggests a much wider
involvement of keratins in desmosome assembly and
turnover. Remarkably, desmocollin misexpression alters
b-catenin stability and epidermal differentiation, a mech-
anism which could potentially contribute to the papillary
downgrowth (Hardman et al. 2005). Whereas the trans-
port of melanosomes in melanocytes is mediated through
actin- and myosin-based motor proteins, with no known
involvement of IF proteins, very little is known about
their distribution and turnover in keratinocytes (Marks
and Seabra 2001). Haploinsufficiency of K5 as the cause
of DDD strongly suggests that keratins are crucial in the
organization of cell adhesion, melanosome uptake into
keratinocytes, organelle transport, and nuclear anchor-
age. This indicates their involvement in intracellular
Figure 5 Immunofluorescence and biochemical analysis of transfected MCF-7 and HaCaT cells stably expressing an EYFP-p.Ile140fs
fusion protein. A and B, MCF-7 cells showing random distribution of the K5 head domain throughout transfectants, including nuclei. Staining
for K18, representative of endogenous keratins, revealed no colocalization of EYFP-p.Ile140fs with endogenous keratins (B). Stably transfected
MCF-7 cells are stained with antibodies against actin (C), desmoplakin (DP) (D), plakophilin 2 (PP2) (E), and plakophilin 3 (PP3) (F). Stably
transfected HaCaT keratinocytes are stained with antibodies against plakophilin 1 (PP1) (I) and a-tubulin (J). In both cell lines, no colocalization
or altered distribution between EYFP-p.Ile140fs and any of these proteins was detected. In MCF-7 cells, a partial colocalization of EYFP-
p.Ile140fs (yellow overlay) with dynein intermediate chain (G), but not with a-tubulin (H), was detected. Fractionation and immunoblotting
of MCF-7 cells stably transfected with EYFP-p.Ile140fs and mock-transfected controls (K). Blots containing total (T), soluble (S), and Triton/
high-salt–insoluble cytoskeletal proteins (C) were incubated with antibodies against EYFP, K8, K18, and K19. EYFP-p.Ile140fs was detected
exclusively in the soluble fraction harvested from transfected MCF-7 cells, without affecting the solubility of endogenous keratins. Scale bar
represents 20 mm.
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transport, a function deemed so far to be restricted to
microtubules and microfilaments.
In regard to a possible pathophysiological mechanism,
we hypothesize that the K5 haploinsufficiency causes an
excess of K14 that is not stabilized in heterodimeric com-
plexes and filaments associated with K5. An excess of
unpaired, soluble K14 may, therefore, be responsible for
the pathology of DDD by competing with transport
adapters, an analogy to soluble vimentin (Perlson et al.
2005). How could an excess of K14 interfere with me-
lanosome uptake and localization? Recently, the keratin-
related IF proteins vimentin, peripherin, and a-inter-
nexin were identified as proteins interacting directly with
the d-subunit of the adapter complex AP-3. In vimentin-
deficient cells, lysosomal pH was less acidic, and vesic-
ular zinc uptake and the surface content of AP-3 cargoes
were significantly altered (Styers et al. 2004). In a similar
fashion, keratins could regulate the availability and po-
sitioning of AP-3 complexes in keratinocytes. Alterna-
tively, keratins could regulate the interaction of AP-3-
dependent vesicles with motor proteins and, thereby,
affect organelle transport and membrane protein trans-
port. Of note, in addition to kinesin and dynein family
members, all of which are known to bind to IF proteins,
myosin V interacts with IF proteins (Rao et al. 2002;
Chang and Goldman 2004). Given that myosin V mu-
tations cause the pigmentation disorder Griscelli syn-
drome, alterations in keratin composition and organi-
zation could interfere with melanosome uptake in
keratinocytes (Marks and Seabra 2001). Melanosome
localization in keratinocytes has been suggested to in-
volve the retrograde motor protein cytoplasmic dynein
(Byers et al. 2003). Dynein is also known to play a major
role in the retrograde transport of IF proteins. Con-
versely, the availability of dynein can be regulated by
interaction with IF proteins (Chang and Goldman 2004).
The importance of soluble IF proteins for long-range
transport has been highlighted by the finding that soluble
vimentin mediates the binding of activated mitogen-ac-
tivated protein kinases to dynein via importin b (Perlson
et al. 2005). K5 haploinsufficiency in DDD and the K5
p.Pro25Leu mutation in EBS with mottled pigmentation
represent the only genetic entities described to date to
cause a melanosome disorder in keratinocytes. Unlike
Hermansky-Pudlak and Griscelli syndromes, which af-
fect melanocytes, DDD and EBS with mottled pigmen-
tation offer a unique approach to gain a mechanistic
insight into melanosome uptake and for the analysis of
vesicle transport in keratinocytes. Finally, our finding
that K5 haploinsufficiency is a cause of DDD sounds a
cautionary note for therapy approaches of dominant
keratinopathies, including EBS, aiming at down-regu-
lation of mutant alleles.
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